Skip to Main Content
Phase II

Pregnenolone for Alcohol Use Disorder

  • Study HIC#:2000034929
  • Last Updated:05/03/2024

The purpose of this 12-week study is to see if pregnenolone, a naturally occurring hormone, reduces alcohol intake and the desire to use alcohol in individuals with alcohol use disorder. Participation involves weekly or biweekly visits to the Yale Stress Center in New Haven, as well as free weekly counseling sessions.

Total estimated compensation is $1574.

For information contact: Yale Stress Center at 1-877-Y-STRESS(1-888-978-7377) or email: stress@yale.edu

  • Age18 years - 70 years
  • GenderBoth

Contact Us

For more information about this study, including how to volunteer, contact:

Yale Stress Center

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Trial Purpose and Description

The purpose of this 12-week study is to see if pregnenolone, a naturally occurring hormone, reduces alcohol intake and the desire to use alcohol in individuals with alcohol use disorder. Participation involves weekly or biweekly visits to the Yale Stress Center in New Haven, as well as free weekly counseling sessions.

Total estimated compensation is $1574.

For information contact: Yale Stress Center at 1-877-Y-STRESS(1-888-978-7377) or email: stress@yale.edu

Eligibility Criteria

  • Inclusion Criteria:
    • Male and females, aged 18-70 years;
    • Able to read English and complete study evaluations and provide informed written and verbal consent.
  • Exclusion Criteria:
    • Women who are pregnant, nursing or refuse to use a reliable form of birth control.

Principal Investigator

Sub-Investigators

For more information about this study, including how to volunteer, contact: